A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis

OBJECTIVE: To evaluate the immunogenicity, safety, and efficacy of etanercept (ETN) manufactured using the serum-free, high-capacity manufacturing (SFHCM) process in patients with rheumatoid arthritis (RA). METHODS: In this global, multicenter, open-label, single-arm study (NCT02378506), 187 adult p...

Descripción completa

Detalles Bibliográficos
Autores principales: Polák, Pavol, Peric, Porin, Louw, Ingrid, Gaylord, Stefanie M., Williams, Theresa, Becker, Jean-Claude, Pedersen, Ron, Korth-Bradley, Joan, Vlahos, Bonnie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Research and Education Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459335/
https://www.ncbi.nlm.nih.gov/pubmed/30451655
http://dx.doi.org/10.5152/eurjrheum.2018.18078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459335/
https://www.ncbi.nlm.nih.gov/pubmed/30451655
http://dx.doi.org/10.5152/eurjrheum.2018.18078

Ejemplares similares